Literature DB >> 3598909

Selective induction of propranolol metabolism by smoking: additional effects on renal clearance of metabolites.

T Walle, U K Walle, T D Cowart, E C Conradi, T E Gaffney.   

Abstract

The objective of this study was to examine the effect of cigarette smoking on the activities of the three primary pathways governing propranolol metabolism in human subjects, i.e., glucuronidation, side-chain oxidation and ring oxidation. A single 80-mg dose of propranolol p.o. together with 40 muCi of 4-[3H]propranolol was given to six smoking and seven nonsmoking, young, white, male subjects and the oral clearance of propranolol and the partial clearances through these pathways were determined. The oral clearance of propranolol was increased by 77% (P less than .02) in smokers compared with nonsmokers. This apparent induction of propranolol metabolism was due to a 122% increase in side-chain oxidation (P less than .001) and a 55% increase in glucuronidation (P less than .01). There was no significant effect of smoking on aromatic ring oxidation. Smokers had a 30% greater renal clearance of total metabolites (P less than .05), due mainly to a 53% greater renal clearance of the acidic propranolol metabolite naphthoxylactic acid (P less than .001). These data show a selective effect of smoking on propranolol metabolism and suggest that side-chain oxidation and glucuronidation are mediated by isoenzymes inducible by aromatic hydrocarbons. The selective effect of smoking on the renal clearance of the major propranolol metabolite naphthoxylactic acid may be due to induction of a renal transport protein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3598909

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

Review 1.  beta-blockers. Drug interactions of clinical significance.

Authors:  I Blaufarb; T M Pfeifer; W H Frishman
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

2.  Induction of cytochrome P450 1A by cow milk-based formula: a comparative study between human milk and formula.

Authors:  Haibo Xu; Ratheishan Rajesan; Patricia Harper; Richard B Kim; Bo Lonnerdal; Mingdong Yang; Satoko Uematsu; Janine Hutson; Jo Watson-MacDonell; Shinya Ito
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

3.  Inhibitory effects of antiarrhythmic drugs on phenacetin O-deethylation catalysed by human CYP1A2.

Authors:  K Kobayashi; M Nakajima; K Chiba; T Yamamoto; M Tani; T Ishizaki; Y Kuroiwa
Journal:  Br J Clin Pharmacol       Date:  1998-04       Impact factor: 4.335

Review 4.  Drug interactions with tobacco smoking. An update.

Authors:  S Zevin; N L Benowitz
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

5.  Influence of cigarette smoking on melatonin levels in man.

Authors:  Carina Ursing; Christer von Bahr; Kerstin Brismar; Sven Röjdmark
Journal:  Eur J Clin Pharmacol       Date:  2005-04-12       Impact factor: 2.953

Review 6.  Impact of smoking on asthma therapy: a critical review of clinical evidence.

Authors:  Eric Livingston; Neil C Thomson; George W Chalmers
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers--N-desisopropylation is mediated mainly by CYP1A2.

Authors:  K Yoshimoto; H Echizen; K Chiba; M Tani; T Ishizaki
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

8.  Propranolol is a mechanism-based inhibitor of CYP2D and CYP2D6 in humanized CYP2D6-transgenic mice: Effects on activity and drug responses.

Authors:  Edgor Cole Tolledo; Sharon Miksys; Frank J Gonzalez; Rachel F Tyndale
Journal:  Br J Pharmacol       Date:  2020-01-06       Impact factor: 8.739

9.  Does cigarette use modify blood pressure measurement or the effectiveness of blood pressure medications?

Authors:  Debbie L Cohen; Raymond R Townsend
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-11       Impact factor: 3.738

10.  Should beta blockers be used in the treatment of hypertension in the elderly?

Authors:  L Michael Prisant
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Jul-Aug       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.